Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland

Sexually Transmitted Infections

Volumn 81, Issue 3, 2005, Pages 248-253

  Plitt, S S ^a   Sherman, Susan G ^a   Strathdee, S A ^b   Taha, T E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; DEMOGRAPHY; DRUG ABUSE; EMPLOYMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; REAGIN TEST; SELF REPORT; SEROPREVALENCE; SEX RATIO; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; SYPHILIS; TREPONEMA PALLIDUM; TREPONEMA PALLIDUM HEMAGGLUTINATION TEST; UNITED STATES;

ADOLESCENT; ADULT; BALTIMORE; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SUBSTANCE-RELATED DISORDERS; SYPHILIS;

EID: 20644436252     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2004.011544     Document Type: Article

References (28)

1. Rottingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known? Sex Transm Dis 2001;28:579-97.
2. Dickerson MC, Johnston J, Delea TE, et al. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996;23:429-40.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
4. Spinola SM, Orazi A, Arno JN, et al. Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. J Infect Dis 1996;173:394-402.
5. Schocker T, Ryncarz AJ, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998;280:61-6.
6. Cohen E, Navaline H, Metzger D. High-risk behaviors for HIV: a comparison between crack-abusing and opioid-abusing African-American women. J Psychoactive Drugs 1994;26:233-41.
7. Kim MY, Marmor M, Dubin N, et al. HIV risk-related sexual behaviors among heterosexuals in New York City: associations with race, sex, and intravenous drug use. AIDS 1993;7:409-14.
8. Henderson DJ, Boyd C, Mieczkowski T. Gender, relationships, and crack cocaine: a content analysis. Res Nurs Health 1994;17:265-72.
9. Powis B, Griffiths P, Gossop M, et al. The differences between male and female drug users: community samples of heroin and cocaine users compared. Subst Use Misuse 1996;31:529-43.
10. Carlson RG, Wang J, Siegal HA, et al. An ethnographic approach to targeted sampling: problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Human Organization 1994;53:279-86.
11. Fuller CM, Vlahov D, Ompad DC, et al. High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend 2002;66:189-98.
12. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995;8:1-21.
13. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
14. Cherpes TL, Meyn LA, Krohn MA, et al. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex Transm Dis 2003;30:405-10.
15. Hahn RA, Magder LS, Aral SO, et al. Race and the prevalence of syphilis seroreactivity in the United States population: a national sero-epidemiologic study. Am J Public Health 1989;79:467-70.
16. Centers for Disease Control. Primary and secondary syphilis-United States, 2000-2001. MMWR Morb Mortal Wkly Rep 2002;51:971-3.
17. Gottlieb SL, Douglas JM Jr, Schmid DS, et al. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis 2002;186:1381-9.
18. Finelli L, Farley TP, Gibson JJ, et al. Prevalence monitoring in syphilis surveillance: results from a multicenter research program. Sex Transm Dis 2002;29:769-774.
19. Stanberry L, Cunningham A, Mertz G, et al. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res 1999;42:1-14.
20. Musher DM. Chapter 35: Early syphilis. In: Holmes KK, Sparling PF, Mardh P-A, Lemon SM, Stamm WE, Piot P, et al, eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999:479-85.
21. McCoy CB, Metsch LR, Chitwood DD, et al. Drug use and barriers to use of health care services. Subst Use Misuse 2001;36:789-806.
22. Lapez-Zetina J, Ford W, Weber M, et al. Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6. Sex Transm Infect 2000;76:462-9.
23. Williams ML, Elwood WN, Weatherby NL, et al. An assessment of the risks of syphilis and HIV infection among a sample of not-in-treatment drug users in Houston, Texas. AIDS Care 1996;8:671-82.
24. Ross MW, Hwang LY, Leonard L, et al. Sexual behaviour, STDs and drug use in a crack house population. Int J STD AIDS 1999;10:224-30.
25. Hwang LY, Ross MW, Zack C, et al. Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin Infect Dis 2000;31:920-6.
26. Bruneau J, Lamothe F, Soto J, et al. Sex-specific determinants of HIV infection among injection drug users in Montreal. CMAJ 2001;164:767-73.
27. Evans JL, Hahn JA, Page-Shafer K, et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health 2003;80:137-46.
28. Stamm LV. Chapter 33: Biology of Treponema pallidum. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, et al, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1999.